Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment

SARS-CoV-2 is a novel β-coronavirus that caused the COVID-19 pandemic disease, which spread rapidly, infecting more than 134 million people, and killing almost 2.9 million thus far. Based on the urgent need for therapeutic and prophylactic strategies, the identification and characterization of antib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Microb Cell Fact
Main Authors: Valdez-Cruz, Norma A., García-Hernández, Enrique, Espitia, Clara, Cobos-Marín, Laura, Altamirano, Claudia, Bando-Campos, Carlos G., Cofas-Vargas, Luis F., Coronado-Aceves, Enrique W., González-Hernández, Ricardo A., Hernández-Peralta, Pablo, Juárez-López, Daniel, Ortega-Portilla, Paola A., Restrepo-Pineda, Sara, Zelada-Cordero, Patricio, Trujillo-Roldán, Mauricio A.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8061467/
https://ncbi.nlm.nih.gov/pubmed/33888152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12934-021-01576-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados